The global cold plasma market size was estimated at USD 167.8 million in 2025 and is projected to reach USD 495.9 million by 2033, growing at a CAGR of 14.6% from 2026 to 2033. This growth is attributed to the overall development of the healthcare industry, which has increased the demand for advanced technologies to enhance patient treatment procedures and make them safe and non-invasive. Rising adoption of innovative medical technologies and increasing focus on improving treatment efficiency and patient outcomes are also contributing significantly to market growth worldwide.

Cold plasma technology is increasingly being utilized across healthcare and medical applications due to its ability to provide antimicrobial effects, sterilization, tissue regeneration, and wound healing support without causing significant thermal damage to tissues. The technology is gaining attention for its effectiveness in treating chronic wounds, infections, and skin-related conditions. Growing investments in healthcare infrastructure and increasing research activities focused on plasma-based medical technologies are supporting the expansion of the cold plasma market globally.

Download a free sample copy of the Cold Plasma market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

• North America's cold plasma market held the largest share of 40.4% of the global market in 2025. The region’s dominance is supported by advanced healthcare infrastructure, rising healthcare expenditure, increasing adoption of innovative medical technologies, and strong research and development activities. The presence of major healthcare technology companies and increasing demand for non-invasive treatment solutions are further contributing to market growth across North America. In addition, growing awareness regarding advanced wound care therapies and infection control technologies is supporting regional market expansion.
• The U.S. cold plasma industry is expected to grow significantly over the forecast period. The country continues to witness increasing adoption of advanced healthcare technologies and growing demand for innovative treatment procedures in hospitals and healthcare facilities. Rising prevalence of chronic wounds, surgical site infections, and skin disorders is driving demand for cold plasma treatment solutions in the U.S. Furthermore, increasing healthcare investments and expanding clinical research activities related to plasma medicine are supporting market growth within the country.
• By pressure, the atmospheric pressure cold plasma segment held the largest market share of 63.8% in 2025. Atmospheric pressure cold plasma systems are widely preferred because they can operate under normal atmospheric conditions without requiring expensive vacuum equipment. These systems are extensively utilized in medical sterilization, wound healing, surface treatment, and infection control applications. The growing demand for cost-effective and efficient plasma treatment technologies is contributing significantly to the dominance of this segment within the market.
• By application, the wound healing segment held the leading market share in 2025. Cold plasma technology is increasingly used in wound healing applications due to its ability to reduce bacterial contamination, stimulate tissue regeneration, and accelerate the healing process. The rising prevalence of chronic wounds, diabetic ulcers, burns, and post-surgical wounds is driving demand for advanced wound care solutions globally. Increasing focus on improving patient recovery outcomes and reducing infection risks is further supporting the growth of the wound healing segment in the cold plasma market.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

The cold plasma market is characterized by its dynamic and competitive nature. The market is led by key players such as Apyx Medical, neoplas med GmbH, Adtec Healthcare Limited, and US Medical Innovations, LLC, among others. Companies are heavily investing in research and development to introduce innovative products with better imaging capabilities and reduced radiation exposure. There is a notable trend of mergers and acquisitions as companies aim to expand their product portfolios and enter new markets.

Key Cold Plasma Companies:

• Apyx Medical
• neoplas med GmbH
• Adtec Healthcare Limited
• terraplasma GmbH
• CINOGY System GmbH
• Plasmacure
• relyon plasma GmbH
• US Medical Innovations

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering